Intuitive Surgical (NASDAQ:ISRG) Stock: Insider Gary Loeb Sells 400 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $3.70 during trading hours on Friday, hitting $443.59. The company had a trading volume of 1,604,248 shares, compared to its average volume of 2,787,457. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a market capitalization of $153.77 billion, a price-to-earnings ratio of 53.64, a P/E/G ratio of 3.03 and a beta of 1.45. The firm’s 50 day moving average is $417.59 and its 200 day moving average is $429.98.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the previous year, the firm posted $2.40 earnings per share. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Institutional Trading of Intuitive Surgical

Several large investors have recently modified their holdings of the business. Bank of New York Mellon Corp acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $1,335,753,000. Arrowstreet Capital Limited Partnership raised its position in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Assenagon Asset Management S.A. raised its position in shares of Intuitive Surgical by 55.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after acquiring an additional 558,099 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $136,743,000. Finally, Voya Investment Management LLC lifted its stake in Intuitive Surgical by 97.2% during the third quarter. Voya Investment Management LLC now owns 491,914 shares of the medical equipment provider’s stock worth $200,028,000 after purchasing an additional 242,468 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 21st. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Thursday. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Finally, Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $493.54.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.